The Latest Science: Two MS headlines, one week, very different risk
The Latest Science Sep 11th Two MS headlines, one week, very different risk: What "resetting the immune system" actually means ↓ Hi Reader Two immune-treatment stories broke in the same week, and I think they're worth sitting with together. The first: a new oral tablet (a "BTK inhibitor" called remibrutinib) showed strong early results against relapsing MS — better than an existing oral drug on relapse rate and MRI-visible inflammation, with no red flags so far. The second: an intensive...
15 days ago • 1 min readThe Latest Science: The "unifying fatigue theory" headline — what it actually means
The Latest Science Sep 9th The "unifying fatigue theory" headline — what it actually means: Why fatigue cannot be understood one system at a time ↓ Hi Reader You may have seen the headlines this week about a "unifying theory of fatigue" — a new study suggesting that ME/CFS, long Covid, PTSD, rheumatoid arthritis and multiple sclerosis might share common biological roots. As someone who works with fatigued patients every single week, I want to give you the honest version of this story —...
17 days ago • 1 min read